Your browser doesn't support javascript.
loading
Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia.
Xue, Yao; Ge, Yuqiu; Kang, Meiyun; Wu, Cong; Wang, Yaping; Rong, Liucheng; Fang, Yongjun.
Afiliação
  • Xue Y; Department of Hematology and Oncology, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Ge Y; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, China.
  • Kang M; Department of Public Health and Preventive Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, China.
  • Wu C; Department of Hematology and Oncology, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Wang Y; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, China.
  • Rong L; Engineering Research Center of Wideband Wireless Communication Technology, Ministry of Education, Nanjing University of Posts and Telecommunications, Nanjing, China.
  • Fang Y; Department of Hematology and Oncology, Children's Hospital of Nanjing Medical University, Nanjing, China.
BMC Cancer ; 19(1): 109, 2019 Jan 30.
Article em En | MEDLINE | ID: mdl-30700251
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / MicroRNAs Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / MicroRNAs Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China